Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Buti

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|February 16, 2007
Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patientsManuel Crespo, Juan I Esteban, Esteban Ribera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 17, 2018
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantationSabela Lens, María García-Eliz, Inmaculada Fernández, et al.
Annals of Hepatology|April 20, 2011
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?Isabel Campos-Varela, Lluís Castells, María Buti, et al.
Journal of Viral Hepatitis|November 22, 2021
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C eliminationXavier Forns, Joan Colom, Montse García-Retortillo, et al.
Annals of Hepatology|May 23, 2019
Sclerosing Cholangitis Related to IgG4: Not Always a Curable EntityFernando Martínez-Valle, Mar Riveiro-Barciela, María-Teresa Salcedo, et al.
Revista Espanola De Enfermedades Digestivas|December 28, 2019
Principles for implementing a population screening strategy for hepatitis C in SpainJoaquín Cabezas, Federico García, José Luis Calleja Panero, et al.
Journal of Hepatology|May 24, 2003
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantationMaría Buti, Antoni Mas, Martín Prieto, et al.
European Journal of Gastroenterology & Hepatology|March 3, 2012
Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patientsMaría Buti, Rosa Maria Morillas, Martín Prieto, et al.
Medicine|March 3, 2020
Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipientsPatricia Álvarez-López, Mar Riveiro-Barciela, Diana Oleas-Vega, et al.
Plos One|July 29, 2014
Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infectionMar Riveiro-Barciela, María Buti, María Homs, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|February 16, 2007
Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patientsManuel Crespo, Juan I Esteban, Esteban Ribera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 17, 2018
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantationSabela Lens, María García-Eliz, Inmaculada Fernández, et al.
Annals of Hepatology|April 20, 2011
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?Isabel Campos-Varela, Lluís Castells, María Buti, et al.
Journal of Viral Hepatitis|November 22, 2021
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C eliminationXavier Forns, Joan Colom, Montse García-Retortillo, et al.
Annals of Hepatology|May 23, 2019
Sclerosing Cholangitis Related to IgG4: Not Always a Curable EntityFernando Martínez-Valle, Mar Riveiro-Barciela, María-Teresa Salcedo, et al.
Revista Espanola De Enfermedades Digestivas|December 28, 2019
Principles for implementing a population screening strategy for hepatitis C in SpainJoaquín Cabezas, Federico García, José Luis Calleja Panero, et al.
Journal of Hepatology|May 24, 2003
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantationMaría Buti, Antoni Mas, Martín Prieto, et al.
European Journal of Gastroenterology & Hepatology|March 3, 2012
Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patientsMaría Buti, Rosa Maria Morillas, Martín Prieto, et al.
Medicine|March 3, 2020
Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipientsPatricia Álvarez-López, Mar Riveiro-Barciela, Diana Oleas-Vega, et al.
Plos One|July 29, 2014
Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infectionMar Riveiro-Barciela, María Buti, María Homs, et al.
Pageof 10